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Introduction {#sec1}
============

Stem cells are essential for tissue formation, maintenance, and repair by achieving a timely balance between error-free replicative expansion and differentiation. This balance is frequently jeopardized in cancer and aging, leading to tissue pathology and functional decline ([@bib5; @bib39; @bib55]). To ensure accurate segregation of chromosomes during mitosis, the spindle assembly checkpoint (SAC) prevents anaphase onset until each chromosome has attached properly to mitotic spindle microtubules via its kinetochore ([@bib19; @bib37; @bib46]). Therefore, an active SAC will delay mitosis until all chromosomes have been properly attached and aligned.

Many molecular players participate in a spatiotemporally concerted manner to actuate the SAC. These include MAD2 (mitotic arrest deficient 2), MPS1 (monopolar spindle 1), BUB1 (budding uninhibited by benomyl 1), and BUBR1 ([@bib19; @bib37; @bib46; @bib68]). In the presence of improperly attached kinetochores, the SAC arrests cells in mitosis by inhibiting the ability of CDC20 to activate APC/C-mediated polyubiquitination and subsequent proteasomal degradation of securin and cyclin B1 ([@bib27; @bib32]).

SAC disruption in different cellular contexts reveals distinct outcomes. Data from immortalized cell lines and single-cell organisms demonstrate that the consequences of SAC failure include premature onset of anaphase, mitotic slippage, chromosome missegregation, and promotion of aneuploidy ([@bib31; @bib33]). In vivo studies in vertebrates and invertebrates show the consequence of SAC failure to be context dependent. During development, defective SAC activity can be tolerated early during embryogenesis but leads to an eventual loss of viability ([@bib14; @bib16]). Similarly, a reduction in MAD2 and BUBR1 leads to a SAC defect that can be tolerated but accelerates tumor production ([@bib12; @bib43]). In contrast, the SAC is essential during development and adult tissue regeneration in zebrafish ([@bib50; @bib51; @bib52]). Studies on the role of the SAC in stem cells are more limited. Using either germline mutants or developmentally induced *Cre* drivers to delete SAC genes, both hematopoietic stem cells and epidermal stem cells and their respective committed progeny display differential sensitivity to SAC disruption ([@bib17; @bib30]). Sensitivity to SAC dysfunction in epidermal stem cells was associated with increased aneuploidy and apoptosis ([@bib17]).

To date, the role of the SAC exclusively in adult mammalian stem cells has not been addressed. *Pax7*-expressing satellite cells (SCs) possess the function of stem cells and are critical for postnatal growth and repair of adult skeletal muscle ([@bib38; @bib44; @bib60; @bib62]). Using inducible *Pax7*-specific SAC perturbation models, we show that the SAC is essential for normal mammalian SC function, during both early postnatal growth and adult tissue regeneration. Deregulation of the SAC in SC progeny leads to a rapid G1 arrest and missegregation of chromosomes. p21^CIP1^ is critical for the cellular arrest, and its reduction in SAC-defective progenitors permits the expansion of SCs with faulty genomes. Furthermore, we show that SAC activity and the level of aneuploidy are not altered in cycling satellite cells as a function of physiological aging.

Results {#sec2}
=======

Muscle SCs Have a Functional Spindle Assembly Checkpoint {#sec2.1}
--------------------------------------------------------

To investigate whether SCs have a functional spindle assembly checkpoint, we first examined expression of SAC components in quiescent and proliferating SCs. In quiescent SCs isolated by cell-surface markers (lin^−^, Int-a7^+^, Vcam^+^, PI^−^), *Mad2* and *Mps1* transcripts were barely detectable. After 3 days in culture in growth media, their levels were significantly upregulated ([Figure 1](#fig1){ref-type="fig"}A). To characterize the SAC component MAD2 in SCs residing within their niche, we examined single adult muscle fibers ([@bib75]). MAD2 protein as detected by immunohistochemistry was not detectable in SCs at 0 hr but was present in activated (KI67^+^) SCs after 48 hr in culture ([Figure 1](#fig1){ref-type="fig"}B). To analyze MAD2 localization during progression through the cell cycle, we costained single fibers for tubulin and MAD2. In interphase, MAD2 localizes to the nuclear envelope and cytoplasm of activated SCs, but not to the nuclei of the postmitotic muscle fiber ([Figures 1](#fig1){ref-type="fig"}B and 1C; [Figure S1](#mmc1){ref-type="supplementary-material"}). During prometaphase, MAD2 localizes to improperly attached kinetochores and, by late metaphase, when all the chromosomes are aligned, MAD2 redistributes from the kinetochores to the cytoplasm (presumably due to SAC satisfaction) ([Figure 1](#fig1){ref-type="fig"}C; [Figure S1](#mmc1){ref-type="supplementary-material"}). After mitotic exit, MAD2 regains its interphase localization pattern to the nuclear envelope and cytoplasm ([Figure 1](#fig1){ref-type="fig"}C; [Figure S1](#mmc1){ref-type="supplementary-material"}).

To directly examine whether SCs have a functional SAC, we disrupted the mitotic spindle in proliferating SCs resident in their niche by treating them with either the microtubule-depolymerizing drug nocodazole or the monopolar spindle-inducing drug monastrol. Both treatments arrested SCs in mitosis as detected by phosphohistone 3 (pH3) ([Figure 1](#fig1){ref-type="fig"}D) with unattached and/or malattached chromatids ([Figure 1](#fig1){ref-type="fig"}E). In both examples, MAD2 localized on the kinetochores, reflecting a functional SAC ([@bib19; @bib37; @bib46]) ([Figure 1](#fig1){ref-type="fig"}E). These results, for the first time, demonstrate that adult muscle SCs residing in their own niche have a robust SAC.

A Functional SAC Is Necessary for Normal Regenerative Potential of SCs {#sec2.2}
----------------------------------------------------------------------

To examine the role of the SAC in SCs, we disrupted *Mps1*, a dual-specificity kinase with several cellular functions including regulation of microtubule dynamics, SAC regulation, and centrosomal duplication ([@bib40]). The binding of MPS1 to the kinetochore is essential for SAC function ([@bib1; @bib47]). Therefore, to target kinetochore function while maintaining kinase activity intact, we used a conditional *Mps1* mutant (*Mps1Δ f/f*) that is unable to localize to the kinetochore ([Figure S2](#mmc1){ref-type="supplementary-material"}) ([@bib18; @bib21]). This was crossed with mice harboring a tamoxifen (Tmx)-inducible *Pax7-CreER*^*tm*^ allele and *R26R-eYFP* allele (hereafter *Mps1Δ f/f*). Mice containing the mutant *loxP* allele but lacking the *Pax7-CreER*^*tm*^ allele were used as controls.

To determine whether disrupting *Mps1* function exclusively in quiescent SCs would impact muscle regeneration, we administered Tmx prior to injury (−14 days) ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Seven days after injury, the fractions of bromodeoxyuridine-positive (BrdU^+^) cells ([Figures S3](#mmc1){ref-type="supplementary-material"}B and S3C) and muscle fiber size ([Figures S3](#mmc1){ref-type="supplementary-material"}D--S3F) were not different between *Mps1Δ f/f* and control muscles. This raised the possibility that *Mps1* is redundant for SC function in vivo. However, we found incomplete recombination of the *Mps1* locus in enhanced yellow fluorescent protein-positive (eYFP^+^) cells ([Figures S3](#mmc1){ref-type="supplementary-material"}G and S3H). The incongruence between full recombination at the *R26R* locus (indicated by eYFP) and meager recombination at the *Mps1* locus possibly reflects inaccessibility of the CRE recombinase to *loxP* sites in the *Mps1* locus in quiescent SCs.

Due to the elevated expression of SAC genes in proliferating SCs in vitro, we next administered Tmx at early stages of repair (−3 to +3 days after injury) to target *Mps1* in proliferating SCs ([Figure 2](#fig2){ref-type="fig"}A). Two days after the final Tmx treatment, a high degree of recombination was evident in fluorescence-activated cell sorting (FACS)-purified myogenic cells from regenerating muscle of *Mps1Δ f/f* mice based on expression of *R26R-eYFP* (89% of SCs were eYFP^+^) and disruption of *Mps1* at the genomic level ([Figures S3](#mmc1){ref-type="supplementary-material"}G and S3H), suggesting increased accessibility of the *Mps1* locus to CRE recombinase as SCs transition from a quiescent to a proliferative state.

Analysis of regenerating muscle, 7 days after injury, shows that proliferation of SC-derived progeny, based on 5-ethynyl-2′-deoxyuridine (EdU) incorporation, was significantly reduced in *Mps1Δ f/f* compared to control muscles ([Figures 2](#fig2){ref-type="fig"}A and 2B). In addition, muscle fiber size was smaller, suggesting a delay in muscle repair ([Figures 2](#fig2){ref-type="fig"}D and 2E). Thirty days after injury, muscle fiber size in *Mps1Δ f/f* mice remained smaller than both control regenerated muscle and uninjured contralateral muscle, suggesting a permanent defect in muscle repair in the absence of a functional SAC ([Figures 2](#fig2){ref-type="fig"}D and 2E). In addition, we observed 40% fewer sublaminar SCs of regenerated *Mps1Δ f/f* compared to control muscles ([Figures 2](#fig2){ref-type="fig"}F and 2G). In normal muscle, SCs repopulate the niche after muscle injury, restoring the stem cell pool back to homeostatic levels ([@bib59; @bib63]). Therefore, the present results show that the SAC is essential for replenishment and homeostasis of the SC pool after injury.

SAC Is Essential for Normal SC Expansion and Differentiation during Postnatal Muscle Growth {#sec2.3}
-------------------------------------------------------------------------------------------

We next examined the requirement for the SAC in SCs during postnatal myogenesis. To this end, we quantified the number of PAX7^+^ cells, their progeny, and muscle fiber size during postnatal maturation. Tmx was administered from postnatal day 1 (P1) to P4 followed by a 3-day chase ([Figure 3](#fig3){ref-type="fig"}A). At P7, we observed a high degree of recombination at both the endogenous *Mps1* locus and *R26R* locus, as determined by eYFP expression ([Figures S3](#mmc1){ref-type="supplementary-material"}G and S3H). Immunotypic analysis at P7 revealed that *Mps1Δ f/f* muscle had 35%--60% fewer myogenic cells compared to control muscle, as assessed by the number of PAX7^+^, MYOD^+^, and myogenin^+^ cells ([Figures 3](#fig3){ref-type="fig"}B and 3C). In support, administration of EdU from P6 to P7 revealed a 50% decline in the number of proliferating (EdU^+^) myogenic cells ([Figure 3](#fig3){ref-type="fig"}D). Furthermore, a 50% decline in muscle cross-sectional area and a commensurate decline in individual muscle fiber cross-sectional area were observed in *Mps1Δ f/f* compared to control muscle ([Figures 3](#fig3){ref-type="fig"}E--3G). Together, these results demonstrate that a defective SAC limits expansion and lineage progression of the SC pool that severely limits muscle growth during postnatal maturation.

MAD2 Depletion Phenocopies MPS1 Truncation {#sec2.4}
------------------------------------------

To assess SAC signaling during myogenesis, we conditionally disrupted *Mad2* ([@bib17]), a downstream effector of *Mps1* ([@bib24; @bib71]). In agreement with our *Mps1* loss-of-function studies, we observed significantly smaller muscle fibers in both regenerating adult muscle ([Figure S4](#mmc1){ref-type="supplementary-material"}A) and postnatal muscle ([Figure S4](#mmc1){ref-type="supplementary-material"}B) in *Mad2f/f* compared to control mice. In conclusion, the disruption of *Mps1* and *Mad2* severely compromises mammalian muscle stem cell function and underscores the importance of the SAC pathway during muscle growth and repair.

SAC Defect Induces a Rapid G1 Cell-Cycle Arrest and Aneuploidy {#sec2.5}
--------------------------------------------------------------

The ability of stem cells to successfully repair tissue is critically dependent on the number and differentiation potential of their progeny. To determine the acute cellular consequence of SAC dysfunction, we disrupted *Mps1* and *Mad2* function in SC-derived progenitors (hereafter referred to as myoblasts) in vitro using Adeno-GFP-CRE (Ad-CRE) virus. Adeno-GFP was used as a control. We observe that Ad-CRE-treated *Mps1Δ f/f* and *Mad2f/f* myoblasts fail to expand and proliferate in high-serum conditions, as determined by quantification of cell numbers ([Figure 4](#fig4){ref-type="fig"}A; [Figure S6](#mmc1){ref-type="supplementary-material"}A). In addition, a 24-hr BrdU pulse administered 18 hr after virus treatment revealed a dramatic reduction in BrdU uptake ([Figure 4](#fig4){ref-type="fig"}B; [Figures S5](#mmc1){ref-type="supplementary-material"}A and [S6](#mmc1){ref-type="supplementary-material"}B), consistent with a reduction in S phase entry occurring within the following cell cycle.

Next, to evaluate SAC competence, Ad-CRE and Ad-GFP virus-treated *Mps1Δ f/f* myoblasts were subjected to the mitotic poison nocodazole before their entry into mitosis. In this assay, nocodazole normally elicits a mitotic arrest response; cells that bypass the arrest are SAC defective. Compared to controls, *Mps1Δ f/f* myoblasts failed to arrest in mitosis, as evidenced by a reduction in the fraction of pH3^+^ cells ([Figures 4](#fig4){ref-type="fig"}C and 4D). Therefore, myoblasts lacking *Mps1* and *Mad2* function cannot mount an appropriate SAC response. Finally, cell-cycle analysis shows that *Mps1Δ f/f* myoblasts in high-serum conditions are stalled primarily in G1, with far fewer cells entering S phase ([Figure 4](#fig4){ref-type="fig"}E; [Figure S5](#mmc1){ref-type="supplementary-material"}B). In support, *cyclin D1* transcript levels are enriched ([Figure 4](#fig4){ref-type="fig"}F). Thus, SAC disruption leads to mitotic slippage and a rapid arrest in G1 phase of the cell cycle.

SAC dysfunction has been associated with chromosome instability and aneuploidy ([@bib18]). To investigate whether SAC defects lead to chromosome instability in myoblasts, we assayed chromosome number using interphase fluorescence in situ hybridization (FISH) against chromosomes 15 and 19. We find an almost 2-fold increase in the number of aberrantly segregated chromosomes 24 hr following virus treatment in *Mps1Δ f/f* and *Mad2f/f* myoblasts compared to controls ([Figures 4](#fig4){ref-type="fig"}G and 4H). These data are consistent with a direct role of the SAC in prevention of aneuploidy in SC progeny.

Differentiation Is Aborted after SAC Disruption {#sec2.6}
-----------------------------------------------

Cell-fate decisions are controlled in G1 phase of the cell cycle ([@bib49]). Therefore, we examined the cell fate of myoblasts shortly after SAC-dependent cell-cycle arrest. Analysis of apoptosis by Annexin V staining 48 hr after virus treatment revealed a relatively higher necrotic and apoptotic fraction in *Mps1Δ f/f* myoblasts. However, almost 90% of *Mps1Δ f/f* myoblasts are neither apoptotic nor necrotic ([Figure 5](#fig5){ref-type="fig"}A). In addition, senescence-associated β-galactosidase staining revealed negligible and comparable senescence between control and *Mps1Δ f/f* myoblasts ([Figures 5](#fig5){ref-type="fig"}B and 5C). Thus, SAC disruption in myoblasts does not substantially increase cell death or senescence.

Next, to determine whether G1-arrested *Mps1Δ f/f* and *Mad2f/f* myoblasts are capable of entering the myogenic differentiation program, we subjected them to serum withdrawal, an inductive environment for differentiation. In these conditions, control myoblasts lose PAX7 expression and turn on myogenin; *Mps1Δ f/f* and *Mad2f/f* myoblasts retain PAX7 and fail to upregulate myogenin ([Figures 5](#fig5){ref-type="fig"}D and 5E; [Figure S6](#mmc1){ref-type="supplementary-material"}C). In addition, *Mps1Δ f/f* myoblasts exhibit 40%--80% lower levels of *MyoD* and *myogenin* transcripts under both proliferation and differentiation conditions ([Figure 5](#fig5){ref-type="fig"}F). Thus, *Mps1Δ f/f* myoblasts are incapable of executing a differentiation program. To examine this defect further, we cultured control and *Mps1Δ f/f* myoblasts in low serum at high cell density to induce myoblast fusion. Control myoblasts effectively form multinucleated myotubes. In contrast, only very rare *Mps1Δ f/f* myoblasts are able to fuse and form multinucleated myotubes ([Figures 5](#fig5){ref-type="fig"}G and 5H). The tumor suppressor *pRB* is essential for effective differentiation of myoblasts ([@bib25; @bib26; @bib74; @bib20; @bib53]). Under differentiation conditions, we find that pRB levels are significantly lower in *Mps1Δ f/f* compared to control myoblasts ([Figure 5](#fig5){ref-type="fig"}J). Therefore, an acute loss of SAC function in committed progenitors renders them incompetent for differentiation.

Elevated *p21* Levels in SAC-Deficient Myoblasts Induce a Reversible G1 Arrest {#sec2.7}
------------------------------------------------------------------------------

Cell-cycle inhibitors balance cell replication and differentiation in normal healthy cells and induce cell-cycle arrest under conditions of DNA damage and chromosomal abnormalities ([@bib22; @bib35]). We find elevated transcript levels of the cellular stress component *p21*^*Cip1*^ (hereafter called *p21*) in adult Ad-CRE-treated *Mps1Δ f/f* myoblasts and FACS-sorted SCs from Tmx-treated *Mps1Δ f/f* neonatal mice compared to controls ([Figures 6](#fig6){ref-type="fig"}A--6D). At the transcript level, other cell-cycle inhibitors such as *p53*, *p16*^*INK4a*^, and *p19*^*ARF*^ were not responsive to SAC-induced arrest ([Figure S7](#mmc1){ref-type="supplementary-material"}). To investigate whether elevated *p21* participates in the SAC-induced cell-cycle arrest and differentiation block, we reduced *p21* levels in SAC-deficient cells using small hairpin RNA (shRNA) lentiviral constructs against *p21* (*p21*KD) or scrambled shRNA (scr) ([Figure 6](#fig6){ref-type="fig"}E). In high-serum conditions, as expected, the majority of *Mps1Δ f/f* cells treated with scr do not proliferate, as indicated by the absence of EdU incorporation. In contrast, *p21*KD-*Mps1Δ f/f* cells are now able to resume the cell cycle, as determined by EdU incorporation. In addition, when switched to low-serum conditions, myogenin is upregulated, consistent with a reversal of the differentiation block ([Figures 6](#fig6){ref-type="fig"}F and 6G). The major cellular component regulating *p21* during cellular stress is the tumor suppressor *p53* ([@bib15; @bib13; @bib23; @bib36; @bib54; @bib61]). Therefore, we investigated whether reducing *p53* levels by lentiviral shRNA would also unlock the cell-cycle arrest in *Mps1Δ f/f* cells. We find that EdU incorporation and differentiation in *p53*KD-*Mps1Δ f/f* cells was significantly increased compared to shRNA-control-*Mps1Δf/f* cells. In control cells, proliferation and differentiation were not affected after *p53*KD treatment ([Figures 6](#fig6){ref-type="fig"}H--6J). Therefore, *p21* upregulation and *p53* activity are critical for cell-cycle arrest and aborted differentiation as an acute response to SAC dysfunction.

Finally, we examined whether the reentry into the cell cycle after *p21*KD rescued the mitotic slippage. In sharp contrast to the cell-cycle rescue, reduction of *p21* did not ameliorate the SAC defect (mitotic slippage) in the presence of nocodazole ([Figure 6](#fig6){ref-type="fig"}K; [Figure S6](#mmc1){ref-type="supplementary-material"}D) or the high levels of aneuploidy ([Figure 6](#fig6){ref-type="fig"}L; [Figure S6](#mmc1){ref-type="supplementary-material"}E). Therefore, restoring *p21* levels allows SAC-deficient myoblasts to overcome the G1 arrest and proceed through the cell cycle; however, they proliferate with a defective SAC and elevated levels of aneuploidy.

Aged SCs Have a Robust SAC {#sec2.8}
--------------------------

Aneuploidy confers a proliferative disadvantage on cells and increases across several tissues during aging ([@bib2; @bib69; @bib72]). Aged SCs demonstrate impaired proliferation in vivo and in vitro ([@bib9; @bib10; @bib6]). We hypothesized that SAC defects underlie the age-dependent decline in SC proliferative capacity. To this end, we compared levels of the essential SAC component MAD2 in adult and aged SCs. We find that levels of MAD2 protein do not differ between adult and aged SCs in both interphase and mitosis ([Figures 7](#fig7){ref-type="fig"}A and 7B). Moreover, mitotic poisons elicit a similar response in activated SCs from both aged and adult mice, with cells arresting in mitosis with comparable mitotic indices ([Figure 7](#fig7){ref-type="fig"}C) and MAD2 localizing to the kinetochores ([Figure 7](#fig7){ref-type="fig"}D). Thus, SAC activity is not compromised in SCs as a function of age. In addition, the aneuploidy index, assessed by interphase FISH, in adult and aged SCs is equivalent, whether examined 2 days postisolation to inspect activated SCs or 5 days postisolation to inspect committed progenitor cells ([Figure 7](#fig7){ref-type="fig"}E). In conclusion, the impaired proliferative capacity exhibited by aged muscle stem cells is not due to an impaired SAC or abnormal chromosome segregation during the cell cycle.

Discussion {#sec3}
==========

The long-lived nature of stem cells imperils them to accumulate genomic damage or errors, which may lead to tissue degeneration or oncogenesis, depending on the cellular response to the insult. The SAC is an essential component of mitosis to ensure fidelity of chromosome segregation during replication. Using targeted approaches to target SAC function specifically in skeletal muscle stem cells, we show that the SAC is essential for muscle stem cell function both during early postnatal growth and adult tissue regeneration. Muscle stem cells lacking a functional SAC arrest in G1 phase of the cell cycle with missegregated chromosomes (aneuploidy) and are incapable of differentiation. The cell-cycle inhibitor p21^CIP1^ acts as a gatekeeper to protect muscle stem cells from propagating abnormal genomes at the expense of tissue repair.

Until now, only a handful of studies have investigated the role of the SAC in mammalian stem cells. When *Mad2* is deleted in the murine epidermal lineage, interfollicular epidermal cells sustain growth; in contrast, hair follicular bulge stem cells fail to grow ([@bib17]). Haploinsufficiency of *Mad2* caused a reduction in the absolute numbers and cycling status of immature but not mature hematopoietic progenitor cells in both the spleen and bone marrow ([@bib30]). Thus, in vivo, depending on the cellular context, the requirement of the SAC is variable.

Satellite cells are a heterogeneous pool containing subsets with stem cell properties and others functioning as progenitors ([@bib7; @bib8; @bib34; @bib56]). Based on the present results, we find no evidence for differential requirements of the SAC within satellite cells as they either self-renew or progress along their lineage. However, our results do show that SAC perturbation in quiescent versus activated muscle stem cells results in different phenotypes in terms of cell proliferation and tissue regeneration. We believe this is due to the differential expression patterns of SAC genes in quiescent compared with activated stem cells. Whereas *Mad2* and *Mps1* are robustly expressed by activated stem cells, they are undetectable in quiescent cells. A common mechanism by which cells repress gene expression is by DNA methylation, and we surmise that the *Mad2* and *Mps1* gene locus in quiescent cells might be densely methylated. Indeed, it is known that CRE recombinase is unable to access *loxP* sites inside a methylated locus ([@bib41]), explaining the poor recombination efficiency of the *Mps1* locus that we observe in quiescent stem cells targeted for recombination when compared to activated stem cells or progenitors. Therefore, the efficient deletion of *Mps1* and *Mad2* during postnatal growth and adult repair in contrast to adult uninjured muscle suggests that *Mps1* and *Mad2* loci undergo dynamic changes in methylation status as satellite cells transition between proliferation and quiescence. Although the mechanisms for SAC gene demethylation remain unknown, the findings implicate epigenetic regulation in the stem cell response to injury, specifically acting as a safeguard for genome integrity. Because SAC defects lead to chromosomal instability and tumor formation ([@bib18]), it is conceivable that a quiescent stem cell that cannot upregulate SAC genes, due to epigenetic repression, may harbor some of the properties that drive a stem or progenitor cell into a tumor-initiating cell.

Genotoxic stress in various forms normally triggers cell-cycle checkpoints that induce cellular arrest ([@bib45]). In melanocyte stem cells and hematopoietic stem cells, genotoxic stress in the form of low-dose radiation causes premature differentiation ([@bib29; @bib73]). Immortalized myogenic cells (C2C12) exposed to DNA-damaging agents undergo reversible inhibition of differentiation through an ABL-MYOD-regulated checkpoint ([@bib28; @bib64; @bib65]). Aneuploidy is a genotoxic stress and is detrimental to cell survival; cancer cells that tolerate aneuploidy can propagate themselves ([@bib18; @bib70]). In the present study, we demonstrate that activated SCs subjected to genotoxic stress by aneuploidy do not undergo acute cell death, senescence, or terminal differentiation. Instead, they reside in a stable but reversible G1-arrested state. Therefore, distinct genotoxic stressors may create relatively diverse phenotypes in damaged tissues.

Although studied extensively for its effect on cell proliferation, little is known about the impact of aneuploidy on differentiation. Our data suggest aneuploidy to be detrimental to differentiation to limit tissue contribution of faulty genomes. Although diminished, integration of SCs lacking a functional SAC (based on R26R-eYFP expression and genomic recombination at *Mps1* and *Mad2* loci) into growing and injured regenerating tissue suggests that some SAC-deficient activated SCs are indeed capable of tissue contribution. It will be important to assess the long-term consequences of aneuploidy on the function of a stable postmitotic tissue, such as skeletal muscle. p21 is a cell-cycle inhibitor that can initiate terminal differentiation and cause cell-cycle arrest in response to genotoxic stress, with forced *p21* overexpression inducing differentiation even in high serum ([@bib22; @bib66]). In the present work, we have uncoupled a *p21*-mediated cell-cycle arrest in response to aneuploidy-induced genotoxic stress and for differentiation. We propose that *p21* induction reflects either competence for differentiation or a protective response to cellular stress rather than predicting cell fate.

The differentiation block of myogenic cells undergoing genotoxic stress should be kept in mind while designing therapies for rhabdomyosarcoma (RMS), a soft-tissue sarcoma whose cell of origin is a myogenic precursor ([@bib57]). RMS is notorious for its inability to terminally differentiate, and this is often correlated with poor prognosis ([@bib58]). We speculate that treating RMS with genome-damaging drugs could potentially exacerbate its inability to differentiate. This information might be valuable in designing myodifferentiation therapies for RMS, especially if the RMS is being treated with DNA-damaging agents such as cisplatin or if the RMS in question might be aneuploid, such as embryonic RMS from mosaic variegated aneuploidy patients, who have mutations in the SAC gene *Bub1B*.

Genome integrity is compromised across several different tissues during aging via structural (DNA damage, telomere shortening) and numerical (aneuploidy) aberrations of DNA ([@bib3; @bib5; @bib42]). In fact, aneuploidization during aging has been observed across many somatic tissues ([@bib2]); moreover, overexpression of the SAC gene *BUBR1* can ameliorate many pathologic phenotypes in an accelerated aging model. Despite the dramatic decline in stem cell function during aging ([@bib7; @bib11; @bib4; @bib67]), satellite cells do not undergo age-induced aneuploidization in noninjured muscle ([@bib2]). Importantly, adult SCs undergo limited divisions throughout life, with estimates ranging from four to eight divisions based on a *TetO-H2B-GFP* reporter ([@bib7; @bib8]), which suggests that aneuploidization does not increase as a function of chronological aging in stem cells. Thus, the protective effects of *BUBR1* overexpression against aging might be independent of its role in the SAC. We now show that when aged SCs are induced to proliferate, they are able to mount an equally robust SAC and have comparable levels of aneuploidy relative to proliferating adult SCs. Despite the robust SAC activity in aged SCs, we cannot rule out malfunction in other mitotic processes as an underlying cause for their limited function.

In multicellular organisms, tissue-specific stem cell proliferation is steered toward self-renewal or differentiation for tissue development or regeneration. Thus, fidelity of chromosome segregation is essential during stem cell proliferation so that organs are not built on cells with compromised genomic integrity. Although quiescent SCs in mammals do not express SAC proteins, they are expressed and used diligently by cycling SCs. To ensure genomic integrity during tissue turnover, adult muscle stem cells utilize a p53- and p21-mediated pathway to block the proliferation of cells with a dysfunctional SAC. Thus, the SAC, along with p53 and p21, helps stem cells to maintain a balance between meeting the demands of building the tissue and preserving genomic integrity favoring genome preservation over tissue homeostasis.

Experimental Procedures {#sec4}
=======================

Animals {#sec4.1}
-------

Conditional alleles for *Mad2* and *Mps1* were generated and provided by Peter Sorger ([@bib18; @bib21]). They were crossed with *Pax7-CreER*^*tm*^ mice ([@bib48]) on a C57BL/6 background to carry out tissue-specific deletions. C57BL/6 mice were procured from Charles River Laboratories or from the National Institute on Aging. Mice were used at 4--6 months of age (adult) or 22--24 months (aged). Animals were housed and handled in accordance with the guidelines of the Massachusetts General Hospital Subcommittee on Research Animal Care.

Muscle Injury and Proliferation Assessment {#sec4.2}
------------------------------------------

Muscle injury and analysis of regenerating muscle fibers were performed as previously described ([@bib63]). EdU (Carbosynth) in PBS (2.5 mg/ml) was intraperitoneally injected into adults (two doses of 70 μl/day) and subcutaneously injected into pups (two doses of 20 μl/day). EdU detection was carried out according to the manufacturer's instructions (Click-iT EdU detection; Invitrogen). One dose of 150 μl of 1.5 mg/ml BrdU (Sigma) was intraperitoneally injected into adults along with 2.5 mg/ml BrdU in 5% sucrose water for drinking.

Statistical Analysis {#sec4.3}
--------------------

Experiments were performed in triplicate unless otherwise stated. Data are presented as means ± SEM. Statistical significance was assessed using Student's t test, where results were considered significant at ^∗^p \< 0.05.

Additional methods are discussed in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.
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![Activated Satellite Cells Have a Functional SAC\
(A) Transcript levels of the satellite cell marker *Pax7* and SAC genes *Mps1* and *Mad2* from FACS-purified SCs immediately after isolation (quiescent; QSC) or cultured in high-serum media (activated; ASC) for 3 days. Data were collected from three mice per time point.\
(B) Representative MAD2 and KI67 immunostaining pattern in PAX7^+^ SCs on single muscle fibers either fixed immediately or after 2 days in culture. 4′,6-diamidino-2-phenylindole (DAPI) stains nuclei. n = 3 mice.\
(C) MAD2 (red) and tubulin (green) immunostaining at key stages of the cell cycle on single muscle fibers after 2 days in culture. DAPI stains nuclei blue.\
(D) Number of cells that arrest in mitosis (pH3^+^ cells) after exposure to mitotic poisons. Triplicate data from n = 3 mice were pooled, with 800--2,000 cells per condition.\
(E) Representative images of MAD2 localization in prometaphase (characterized by the tubulin staining pattern) and in the presence of mitotic poisons.\
The scale bars represent 10 μm (B) and 5 μm (C and E). Data are presented as mean ± SEM. ^∗^p \< 0.05. n.d., not detectable. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![*Mps1* Is Required for Normal Muscle Regeneration and Replenishment of the Satellite Cell Pool\
(A) Experimental regime showing mouse strains, Tmx strategy, and injury paradigm.\
(B and C) Representative images (B) and histogram (C) showing EdU incorporation in control and *Mps1Δ f/f* myogenic cells collected 7 days after injury by FACS. n = 3 mice per genotype, with 200--300 cells per condition, performed in triplicate.\
(D) Transverse sections of regenerating muscle from control and *Mps1Δ f/f* mice collected 7 and 30 days after injury, stained for laminin, DAPI, and YFP to quantify muscle fiber size. Regenerated muscle fibers are characterized by centrally located nuclei.\
(E) Quantification of muscle fiber cross-sectional area (CSA) from regenerating control and *Mps1Δ f/f* muscle. n = 4 mice per genotype.\
(F and G) Number (F) and representative images (G) of PAX7^+^ SCs/single muscle fibers after 30 days of regeneration in control and *Mps1Δ f/f* mice. n = 3 mice, with 30--40 myofibers per condition.\
The scale bars represent 20 μm (B) and 50 μm (D and G). Data are presented as mean ± SEM. ^∗^p \< 0.05, ^∗∗^p \< 0.01, Student's t test. See also [Figures S2--S4](#mmc1){ref-type="supplementary-material"}.](gr2){#fig2}

![*Mps1* Function Is Required for Proper Postnatal Muscle Growth\
(A) Experimental regime showing mouse strains and experimental time course.\
(B) Representative images of transverse muscle sections from control and *Mps1Δ f/f* postnatal mice stained with anti-myogenin (red) (arrows), anti-GFP (green), and DAPI (blue).\
(C) Quantification of myogenic cells in transverse sections as assessed by staining for PAX7, MYOD, and myogenin. For *Mps1Δ f/f* animals, only eYFP^+^ cells were counted. n = 3 mice, with 8--10 muscle sections counted per tissue.\
(D) EdU incorporation of myogenic cells collected by FACS fromP7 control and *Mps1Δ f/f* mice. Only eYFP^+^ cells were counted in *Mps1Δ f/f* mice. n = 3 mice per group, with 200--300 cells counted per condition.\
(E) Transverse muscle in postnatal control and *Mps1Δ f/f* mice stained with anti-laminin and DAPI.\
(F and G) Quantification of mean extensor digitorum longus (EDL) muscle fiber CSA (F) and whole EDL muscle CSA (G). n = 3 mice.\
The scale bars represent 20 μm. Data are presented as mean ± SEM. ^∗^p \< 0.05, Student's t test. See also [Figures S2--S4](#mmc1){ref-type="supplementary-material"}.](gr3){#fig3}

![Disruption of *Mps1* Function Induces a Rapid G1 Arrest in Myogenic Progenitors\
Top: experimental regime showing myoblast treatment and phenotypic assays. Satellite cell-derived myoblasts from *Mps1Δ f/f* adult mice treated with either Adeno-GFP (control) or Adeno-GFP-CRE (*Mps1Δ f/f*) virus and recovered in high-serum media.\
(A) Cell growth relative to initial plating density (n = 100--200 cells/well on day 0). n = 3 mice per condition, with 100--200 cells plated in triplicate wells.\
(B) Quantification of BrdU incorporation in control and *Mps1Δ f/f* myoblasts after a 24-hr pulse; n = 3 mice per condition, with 200--500 cells counted in triplicate wells.\
(C) Representative images of control and *Mps1Δ f/f* myoblasts treated with nocodazole showing GFP (to detect viral infection) and cells in mitosis (pH3^+^). DAPI stains nuclei.\
(D) Quantification of progenitors stalled in mitosis (pH3^+^) from control and *Mps1Δ f/f* myoblasts after nocodazole treatment. Between 1,000 and 2,000 cells were counted per condition. The experiment was done in biological triplicate.\
(E) FACS analysis of the cell-cycle distribution of control and *Mps1Δ f/f* myoblasts.\
(F) Relative transcript levels of CyclinD1 between control and *Mps1Δ f/f* myoblasts Triplicate data are from n = 3 mice.\
(G and H) Aneuploidy index scored from interphase FISH analysis of chromosomes 15 (green) and chromosome 19 (red). Arrows indicate aneuploid cells; n = 100--150 cells per condition. The experiment was done in biological triplicate.\
The scale bars represent 50 μm (C) and 10 μm (G). Data are presented as mean ± SEM. ^∗^p \< 0.05, ^∗∗^p \< 0.01, Student's t test. See also [Figures S5](#mmc1){ref-type="supplementary-material"} and [S6](#mmc1){ref-type="supplementary-material"}.](gr4){#fig4}

![Differentiation Is Aborted in Myoblasts Lacking Kinetochore Binding of *Mps1*\
Top: experimental regime showing myoblast treatment and phenotypic assays. Satellite cell-derived myoblasts from *Mps1Δ f/f* adult mice treated with either Adeno-GFP (control) or Adeno-GFP-CRE (*Mps1Δ f/f*) virus and subjected to cell-fate assays in either high- or low-serum culture conditions after recovery.\
(A) FACS plots showing Annexin-V and 7AAD staining to quantify necrotic and apoptotic cells in control and *Mps1Δ f/f* myoblasts 24 hr after virus treatment. Experiments were performed in triplicate; n = 3 mice.\
(B and C) Representative images (B) and quantification (C) of senescence-associated β-galactosidase (SA-B gal) assays. Arrows highlight senescent cells. Experiments were counted in triplicate; n = 3 mice.\
(D and E) Representative images (D) and quantification (E) of low-density cultures from control and *Mps1Δ f/f* myoblasts switched to low-serum conditions. Cultures were stained with anti-GFP (green), anti-myogenin (white), anti-PAX7 (violet), and DAPI (blue). Experiments were counted in triplicate; n = 3 mice.\
(F) Relative transcript levels of myogenic-fate genes in high-serum (proliferation) and low-serum (differentiation) conditions. Triplicate data from n = 3 mice.\
(G and H) Images (G) and quantification (H) of control and *Mps1Δ f/f* myoblasts after switching to low-serum high-density conditions to test myogenic differentiation (anti-myosin heavy chain; green) and fusion potential. n = 3 trials for each experiment from three mice.\
(I and J) Immunofluorescence of pRB under differentiation conditions. n = 3 trials for each experiment from three mice.\
The scale bars represent 10 μm (B and I), 50 μm (D), and 20 μm (G). Data are presented as mean ± SEM. ^∗^p \< 0.05, ^∗∗^p \< 0.01, Student's t test. See also [Figure S6](#mmc1){ref-type="supplementary-material"}.](gr5){#fig5}

![*Mps1Δ f/f* Myoblasts Undergo a p21-Mediated G1 Arrest\
(A--C) Satellite cell-derived myoblasts from *Mps1Δ f/f* adult mice treated with either Adeno-GFP (control) or Adeno-GFP-CRE (*Mps1Δ f/f*) virus and recovered in high-serum media.\
(A) Relative transcript levels of *p21*^*CIP1*^ (*p21*). Triplicate data are from n = 3 mice.\
(B and C) Representative images (B) and quantification (C) of p21^+^ cells from control and *Mps1Δ f/f* cultures. The experiment was performed in biological triplicate, with 200--300 cells counted per condition.\
(D) Relative transcript levels of *p21* from FACS-sorted myogenic cells from *Mps1Δ f/f* and control P7 pups as per [Figure 3](#fig3){ref-type="fig"}A. Triplicate data are from n = 3 mice. Only eYFP^+^ myogenic cells were isolated from *Mps1Δ f/f* pups.\
(E) Experimental regime to knock down p21 and p53 in *Mps1Δ f/f* myoblasts.\
(F and H) Cell proliferation (% EdU^+^ cells).\
(G and I) Terminal myogenic differentiation (% myogenin^+^ cells); 200--300 cells were counted per condition. Experiments were performed in biological triplicate.\
(J) Representative images of control and *Mps1Δ f/f* cultures treated with Scr-shRNA or *p53*KD and pulsed with EdU to mark cycling cells. Arrows indicate red (p53^+^, EdU^+^), white (p53^+^, EdU^−^), and yellow and blue (p53^−^, EdU^+^).\
(K) Mitotic arrest (pH3^+^) after nocodazole treatment; 1,000--2,000 cells were counted per condition. Experiments were performed in biological triplicate.\
(L) Aneuploidy index scored from interphase FISH analysis of chromosomes 15 (green) and chromosome 19 (red). n = 100--150 cells per condition. The experiment was performed in biological triplicate.\
The scale bars represent 5 μm (B) and 20 μm (J). Data are presented as mean ± SEM. ^∗^p \< 0.05, ^∗∗^p \< 0.01, Student's t test. See also [Figures S6](#mmc1){ref-type="supplementary-material"} and [S7](#mmc1){ref-type="supplementary-material"}.](gr6){#fig6}

![Aging Does Not Impact SAC Function and Aneuploidy in Satellite Cells\
(A and B) Representative images of MAD2 protein on activated SCs during interphase (A) and mitosis (B).\
(C) Mitotic poison assay using nocodazole and monastrol treatment on adult and aged activated SCs; n = 3 mice, with 800--2,000 cells counted per condition.\
(D) Representative images of MAD2 localization in mitotic cells in the presence of nocodazole.\
(E) Aneuploidy index on activated satellite cells (2 days postisolation) and progenitor cells (5 days postisolation) measured by FISH on chromosomes 15 and 19. n = 3 mice, with 200 cells counted per condition.\
The scale bars represent 20 μm (A) and 5 μm (B and D). Data are presented as mean ± SEM. ^∗^p \< 0.05.](gr7){#fig7}
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